These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24081379)
1. Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke. Percy M; Somerville MJ; Hicks M; Garcia A; Colelli T; Wright E; Kitaygorodsky J; Jiang A; Ho V; Parpia A; Wong MK J Alzheimers Dis; 2014; 38(4):907-22. PubMed ID: 24081379 [TBL] [Abstract][Full Text] [Related]
2. Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population. Percy M; Moalem S; Garcia A; Somerville MJ; Hicks M; Andrews D; Azad A; Schwarz P; Beheshti Zavareh R; Birkan R; Choo C; Chow V; Dhaliwal S; Duda V; Kupferschmidt AL; Lam K; Lightman D; Machalek K; Mar W; Nguyen F; Rytwinski PJ; Svara E; Tran M; Wheeler K; Yeung L; Zanibbi K; Zener R; Ziraldo M; Freedman M J Alzheimers Dis; 2008 May; 14(1):69-84. PubMed ID: 18525129 [TBL] [Abstract][Full Text] [Related]
3. Iron genes, iron load and risk of Alzheimer's disease. Lehmann DJ; Worwood M; Ellis R; Wimhurst VL; Merryweather-Clarke AT; Warden DR; Smith AD; Robson KJ J Med Genet; 2006 Oct; 43(10):e52. PubMed ID: 17047092 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Berlin D; Chong G; Chertkow H; Bergman H; Phillips NA; Schipper HM Neurobiol Aging; 2004 Apr; 25(4):465-74. PubMed ID: 15013567 [TBL] [Abstract][Full Text] [Related]
6. Are hereditary hemochromatosis mutations involved in Alzheimer disease? Moalem S; Percy ME; Andrews DF; Kruck TP; Wong S; Dalton AJ; Mehta P; Fedor B; Warren AC Am J Med Genet; 2000 Jul; 93(1):58-66. PubMed ID: 10861683 [TBL] [Abstract][Full Text] [Related]
7. Mutation H63D in the HFE gene confers risk for the development of type 2 diabetes mellitus but not for chronic complications. Colli ML; Gross JL; Canani LH J Diabetes Complications; 2011; 25(1):25-30. PubMed ID: 20097100 [TBL] [Abstract][Full Text] [Related]
8. A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population. Małecki MT; Klupa T; Waluś M; Czogała W; Greenlaw P; Sieradzki J Med Sci Monit; 2003 Feb; 9(2):BR91-5. PubMed ID: 12601293 [TBL] [Abstract][Full Text] [Related]
9. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. Robson KJ; Lehmann DJ; Wimhurst VL; Livesey KJ; Combrinck M; Merryweather-Clarke AT; Warden DR; Smith AD J Med Genet; 2004 Apr; 41(4):261-5. PubMed ID: 15060098 [TBL] [Abstract][Full Text] [Related]
10. Lack of association of C282Y and H63D mutations in the hemochromatosis (HFE) gene with diabetes mellitus type 2 in a case-control study of women in Brazil. Gomes KB; Carvalho MG; Coelho FF; Rodrigues IF; Soares AL; Guimarães DA; Fernandes AP Genet Mol Res; 2009 Oct; 8(4):1285-91. PubMed ID: 19876870 [TBL] [Abstract][Full Text] [Related]
11. Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy. Candore G; Balistreri CR; Lio D; Mantovani V; Colonna-Romano G; Chiappelli M; Tampieri C; Licastro F; Branzi A; Averna M; Caruso M; Hoffmann E; Caruso C Blood Cells Mol Dis; 2003; 31(1):57-62. PubMed ID: 12850485 [TBL] [Abstract][Full Text] [Related]
12. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population. Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086 [TBL] [Abstract][Full Text] [Related]
14. HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. Qi L; Meigs J; Manson JE; Ma J; Hunter D; Rifai N; Hu FB Diabetes; 2005 Dec; 54(12):3567-72. PubMed ID: 16306377 [TBL] [Abstract][Full Text] [Related]
15. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy. Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761 [TBL] [Abstract][Full Text] [Related]
16. [The importance of DNA analysis of C282Y, H63D and S65C mutations in the HFE gene]. Drastíková M; Beránek M; Hegerová J; Putzová D Cas Lek Cesk; 2012; 151(9):428-31. PubMed ID: 23102134 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the hemochromatosis gene (HFE) and stroke. Njajou OT; Hollander M; Koudstaal PJ; Hofman A; Witteman JC; Breteler MM; van Duijn CM Stroke; 2002 Oct; 33(10):2363-6. PubMed ID: 12364722 [TBL] [Abstract][Full Text] [Related]
18. Analysis of HFE gene mutations (C282Y, H63D, and S65C) in the Ecuadorian population. Leone PE; Giménez P; Collantes JC; Paz-y-Miño C Ann Hematol; 2005 Feb; 84(2):103-5. PubMed ID: 15517265 [TBL] [Abstract][Full Text] [Related]
19. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Ellervik C; Birgens H; Tybjaerg-Hansen A; Nordestgaard BG Hepatology; 2007 Oct; 46(4):1071-80. PubMed ID: 17828789 [TBL] [Abstract][Full Text] [Related]
20. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]